ImmuCell News

Earnings Call Summary | ImmuCell(ICCC.US) Q1 2024 Earnings Conference

The following is a summary of the ImmuCell Corporation (ICCC) Q1 2024 Earnings Call Transcript:Financial Performance:ImmuCell's Q1 2024 product sales have seen a significant jump of 111% compared to Q

moomoo AI15:28 ET · Conference Call

ImmuCell Corporation (ICCC) Q1 2024 Earnings Call Transcript

ImmuCell Corporation (ICCC) Q1 2024 Earnings Call Transcript

Earnings Call Transcripts13:48 ET

Express News | ImmuCell Reports $7.3M In Product Sales For Quarter Ended March 31, 2024

BenzingaMay 14 16:28 ET

ImmuCell | 10-Q: Quarterly report

SEC announcementMay 14 16:10 ET · Announcements

Express News | ImmuCell Corporation Q1 Basic EPS USD -0.06

ReutersMay 14 16:05 ET

Immucell 1Q Loss $438,000 >ICCC

Immucell 1Q Loss $438,000 >ICCC

Dow JonesMay 14 16:05 ET

ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024

ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically proven and practical products that improve the health and productivity of dairy and beef cattle, today announced its unaudited financial results for the quarter ended March 31, 2024.

GlobeNewswireMay 14 16:05 ET

ImmuCell Anticipates No Change To Preliminary Sales Results For Q1 Ended March 31, 2024 That Were Disclosed On April 9

ImmuCell Anticipates No Change To Preliminary Sales Results For Q1 Ended March 31, 2024 That Were Disclosed On April 9

BenzingaMay 8 13:02 ET

Express News | ImmuCell Corp: Anticipates No Change to Preliminary Sales Results for Q1 Ended March 31, 2024 That Were Disclosed on April 9

ReutersMay 8 13:01 ET

ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2024

Yahoo FinanceMay 8 13:00 ET

12 Health Care Stocks Moving In Tuesday's After-Market Session

GainersJaguar Health (NASDAQ:JAGX) shares rose 25.3% to $0.11 during Tuesday's after-market session. The company's market cap stands at $31.1 million. aTyr Pharma (NASDAQ:LIFE) shares rose 10.45% to $

BenzingaApr 9 16:31 ET

ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024

ImmuCell Corporation (Nasdaq: ICCC) today announced preliminary, unaudited sales results for the first quarter of 2024, which ended March 31, 2024.

GlobeNewswireApr 9 16:05 ET

ImmuCell Shares Fall After $20 Million Mixed Securities Shelf Filing

ImmuCell (ICCC) shares dropped 2.3% in recent Tuesday trading, a day after the company filed a registration statement for the potential sale of $20 million of securities. The regulatory shelf filing c

MT NewswiresApr 2 11:54 ET

ImmuCell Files for $20M Mixed Shelf Offering

Seeking AlphaApr 2 10:38 ET

Earnings Call: ImmuCell Sees Recovery in Q4 Amid 2023 Challenges

InvestingMar 1 04:48 ET

ImmuCell Corporation (NASDAQ:ICCC) Q4 2023 Earnings Call Transcript

Yahoo FinanceFeb 29 08:25 ET

Earnings Call Summary | ImmuCell(ICCC.US) Q4 2023 Earnings Conference

The following is a summary of the ImmuCell Corporation (ICCC) Q4 2023 Earnings Call Transcript:Financial Performance:ImmuCell reported a decline in sales by 6% year on year due to several process chal

moomoo AIFeb 28 13:53 ET · Conference Call

Express News | ImmuCell Q4 2023 EPS $(0.15) Up From $(0.22) YoY; Product Sales $5.1M Up From $3.9M YoY

Moomoo 24/7Feb 27 17:24 ET

ImmuCell GAAP EPS of -$0.15, Revenue of $5.09M

Seeking AlphaFeb 27 16:23 ET

Press Release: ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023

ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023 PORTLAND, Maine, Feb. 27, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or t

Dow JonesFeb 27 16:05 ET